The company's active pharmaceutical ingredient (API) manufacturing
facility located at Ankleshwar (unit 1), Gujarat has received an
Establishment Inspection Report (EIR).
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-eir-from-usfda-for-ankleshwar-facility/articleshow/71255772.cms
Monday, September 23, 2019
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment